Diffusion of accelerated partial breast radiotherapy in the United States: physician-level and patient-level analyses
- PMID: 25185635
- DOI: 10.1097/MLR.0000000000000215
Diffusion of accelerated partial breast radiotherapy in the United States: physician-level and patient-level analyses
Abstract
Purpose: To evaluate diffusion of brachytherapy-based accelerated partial breast radiotherapy (RT) in the United States, a new breast cancer treatment requiring 5 days twice daily, rather than daily treatment for 6-7 weeks. It has limited long-term effectiveness data compared with standard whole breast RT.
Data and methods: We used 2005-2008 Medicare claims for female Medicare beneficiaries receiving RT after breast-conserving surgery merged with physician and area-based data (n=74,254 patient-subjects; n=1901 physicians), applying logistic regression to estimate: (1) proportion of patients for whom the radiation oncologist used brachytherapy-based accelerated RT, and (2) probability a patient received brachytherapy-based accelerated RT, clustering on physician.
Results: Use of accelerated partial breast RT increased over time (8% in 2005 to 17% in 2008). Physician-level analysis indicates rural physicians were less likely to perform accelerated RT [odds ratio (OR): 0.35-0.49; P<0.002)]; as were those licensed 20+years [OR: 0.54; 95% confidence interval (CI), 0.39-0.74]. Overall, 11.7% of patients received accelerated RT. Treatment post 2005 was associated with increasing odds of receiving accelerated RT (P<0.0001). Older age was associated with lower odds of receiving accelerated RT (reference, 66-69 years old, OR: 0.90, P<0.006), as was black (OR: 0.73;95% CI, 0.63-0.85) or other race (OR: 0.80; 95% CI, 0.65-1.00), living in rural areas (OR: 0.8; P<0.0001), or seeing an older physician [20+years postgraduation (OR: 0.7; 95% CI, 0.5-0.9)]. Patients living in counties with more hospitals with advanced RT facilities were more likely to undergo accelerated RT (OR: 1.4; 95% CI, 1.1-1.8).
Discussion: This new technology appears to be in the early phase of diffusion across the United States and is more rapidly being taken up in younger, white patients living in urban and suburban areas with availability of advanced RT facilities. Rural and older patient populations are not tending to undergo the treatment.
Similar articles
-
New Breast Cancer Radiotherapy Technology Confers Higher Complications and Costs Before Effectiveness Proven: A Medicare Data Analysis.Inquiry. 2018 Jan-Dec;55:46958018759115. doi: 10.1177/0046958018759115. Inquiry. 2018. PMID: 29502466 Free PMC article.
-
Variation in receipt of radiation therapy after breast-conserving surgery: assessing the impact of physicians and geographic regions.Med Care. 2013 Apr;51(4):330-8. doi: 10.1097/MLR.0b013e31827631b0. Med Care. 2013. PMID: 23151590 Free PMC article.
-
National variation in the delivery of radiation oncology procedures in the non-facility-based setting.Cancer Med. 2021 Jul;10(14):4734-4742. doi: 10.1002/cam4.4028. Epub 2021 Jun 2. Cancer Med. 2021. PMID: 34076341 Free PMC article.
-
Long-term Impact of CALGB 9343 on Radiation Utilization.J Surg Res. 2020 Dec;256:577-583. doi: 10.1016/j.jss.2020.07.023. Epub 2020 Aug 14. J Surg Res. 2020. PMID: 32805580 Free PMC article.
-
The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):571-580. doi: 10.1016/j.ijrobp.2016.11.009. Epub 2016 Nov 15. Int J Radiat Oncol Biol Phys. 2017. PMID: 28126306
Cited by
-
New Breast Cancer Radiotherapy Technology Confers Higher Complications and Costs Before Effectiveness Proven: A Medicare Data Analysis.Inquiry. 2018 Jan-Dec;55:46958018759115. doi: 10.1177/0046958018759115. Inquiry. 2018. PMID: 29502466 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical